- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03692572
Influence of Early Menopause on Sympathetic Activation and Cardiovascular Function in Older Women
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The current study is recruiting two groups of women aged between 60-70 years old; 1) women who had early natural/non-surgical menopause (age 40-44 yrs) and 2) women who had normal natural/non-surgical menopause (age 50-54). The investigators are recruiting women who do not have any cardiovascular disease, hypertension, diabetes, and other major health issue.
The main hypothesis of the project is that early menopause negatively impacts the heart, blood vessel and nerve system due to the increased length of time with reduced hormone levels; which could explain the relationship between early menopause and greater risk of cardiovascular disease in later life. Sympathetic nerve system and cardiovascular functions will be evaluated in both groups to compare the impact of prolonged hormone deficiency. In addition, current study will examine the impact of inorganic nitrate supplementation (beet root juice) to see if there are any favorable changes after 2 weeks of beet root juice intake. There are 2 main test visits in the current study.
Visit 1. Nerve system test (maximally take about 5 hours): Participants will rest in the supine position for ≥ 20 mins. Resting heart rate, breathing rate, finger blood pressure will be monitored. Cardiac output will be assessed using the acetylene gas rebreathing technique (1 hour). IV will be inserted for blood draw. Nerve signal search will be performed using a thin needle behind knee to find a signal from a specific nerve. At the same time, transcranial Doppler probe will be placed on the head to look at brain blood flow using soft head gear (1-2 hour). After acceptable signals are obtained, baseline data collection will begin. It will be followed by handgrip exercise and hand immersion to cold water to examine neural sympathetic response to different stimuli (30 mins). After this, to evaluate nerve response to different degrees of passive standings, a bed will be tilted to 30° and 60° for 8 mins each. Blood samples will be obtained in the supine resting position and at the end of 60° tilt (45 mins).
Visit 2. Heart and vessel function assessment (Proximately take 2 hours): All measurements are non-invasive for this visit. Participants will rest in the supine position for ≥ 20 mins. Resting heart function will be assessed by ultrasound echocardiography (30mins). Vascular stiffness measurement will be performed using a probe placed on wrist, neck and leg groin area (30 mins). Vascular endothelial function will be measured using flow-mediated dilation and followed by smooth muscle responsiveness test will be performed by measuring brachial artery diameter changes for 10 min following 0.4 mg sublingual nitroglycerin administration (1 hour).
After Visit 1-2, participant will be asked to drink either dietary nitrate supplementation or placebo for 2 weeks (randomly assigned). After 2 weeks intervention, participant will come back for post-intervention tests which are identical to visit 1 and 2.
After completion of the first intervention, participants will have at least 2 weeks of wash-out period. After 2 weeks participant will be back to the lab and repeat the visit 1 and 2, as well as 2 weeks of dietary nitrate supplementation or placebo. (For those who received 2 weeks of nitrate supplementation for the first intervention, it will be a placebo for this intervention. For those who received placebo for the first intervention, it will be a nitrate supplementation for this intervention). After intervention participants will repeat the visit 1 and 2 again.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75231
- Institute for Exercise and Environmental Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy normotensive postmenopausal women
- Current age between 60 and 70 years
- Who have experienced "natural" or non-surgical menopause
Exclusion Criteria:
- Any evidence of cardiopulmonary disease
- History of hormone replacement therapy in the last 5 years
- Chronic kidney disease
- Diabetes mellitus
- Hypertension
- Current abuse of alcohol or drugs and use of tobacco products
- Surgical procedure induced menopause
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Nitrate supplementation
Nitrate rich (6.8 mmol) beet root juice (70ml) twice a day
|
Subjects will drink 70 ml of beet root juice twice a day for 2 weeks.
|
Placebo Comparator: Placebo
Nitrate depleted (0.04 mmol) placebo juice (70ml) twice a day
|
Subjects will drink 70 ml of nitrate depleted placebo juice twice a day for 2 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Muscle sympathetic nerve activity (MSNA)
Time Frame: Change from baseline resting MSNA to 2 weeks post nitrate supplementation resting MSNA
|
Muscle sympathetic nerve activity will be measured using microneurography at the peroneal nerve.
|
Change from baseline resting MSNA to 2 weeks post nitrate supplementation resting MSNA
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac Echocardiogram
Time Frame: Change from baseline cardiac function to 2 weeks post nitrate supplementation resting cardiac function
|
Systolic and diastolic cardiac function will be measured using high resolution ultrasound echocardiogram
|
Change from baseline cardiac function to 2 weeks post nitrate supplementation resting cardiac function
|
Vascular endothelial function
Time Frame: Change from baseline brachial artery endothelial function to 2 weeks post nitrate supplementation brachial artery endothelial function
|
Brachial artery endothelial function will be measured using flow-mediated dilation
|
Change from baseline brachial artery endothelial function to 2 weeks post nitrate supplementation brachial artery endothelial function
|
Arterial stiffness/wave properties
Time Frame: Change from baseline pulse wave velocity and wave reflection to 2 weeks post nitrate supplementation resting pulse wave velocity and wave reflection
|
Central and peripheral pulse wave velocity and wave reflection will be assessed using arterial tonometry
|
Change from baseline pulse wave velocity and wave reflection to 2 weeks post nitrate supplementation resting pulse wave velocity and wave reflection
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Qi Fu, Ph.D., Faculty
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU 032018-052
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menopause
-
Riphah International UniversityCompleted
-
Englewood Hospital and Medical CenterNanohealth, Inc.WithdrawnMenopause SymptomsUnited States
-
Englewood Hospital and Medical CenterNanohealth, Inc.CompletedMenopause SymptomsUnited States
-
University of Colorado, DenverCompletedMenopause | Pre-menopauseUnited States
-
S.LAB (SOLOWAYS)Center of New Medical TechnologiesCompletedMenopause SymptomsRussian Federation
-
BHR Pharma, LLCTerminatedMenopause Related ConditionsGermany
-
Singapore General HospitalRecruitingMenopause | Menopause Related ConditionsSingapore
-
University of ArkansasRecruitingMenopause Related ConditionsUnited States
-
Wake Forest University Health SciencesWithdrawnMenopause Related Conditions
-
I.M. Sechenov First Moscow State Medical UniversityCompletedMenopause Related ConditionsRussian Federation
Clinical Trials on Nitrate supplementation
-
Capital Medical UniversityUnknownNasopharyngeal CarcinomaChina
-
University of VirginiaCompletedArterial Stiffness | Vascular DilationUnited States
-
Northumbria UniversityManchester Metropolitan UniversityCompleted
-
Queen's UniversityCompletedHeart Failure, Systolic
-
Maastricht University Medical CenterCompletedChronic Obstructive Pulmonary DiseaseNetherlands
-
University of VirginiaRecruitingPeripheral Arterial Disease | Peripheral Vascular DiseasesUnited States
-
Wuerzburg University HospitalRecruiting
-
Gladwin, Mark, MDNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Failure | Preserved Ejection Fraction | Pulmonary; HypertensionUnited States
-
Karolinska InstitutetKarolinska University HospitalCompletedHypertension | Cardiovascular DiseaseSweden
-
Heinrich-Heine University, DuesseldorfCompleted